Financial reports
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
4 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
10-Q
2021 Q2
Quarterly report
9 Aug 21
10-Q
2021 Q1
Quarterly report
10 May 21
10-K
2020 FY
Annual report
15 Mar 21
10-Q
2020 Q3
Quarterly report
9 Nov 20
Current reports
8-K
Termination of a Material Definitive Agreement
16 Nov 22
8-K
LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
14 Nov 22
8-K
Other Events
20 Oct 22
8-K
Entry into a Material Definitive Agreement
7 Oct 22
8-K
Tender and Support Agreement
3 Oct 22
8-K
Departure of Directors or Certain Officers
23 Sep 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
20 Sep 22
8-K
Departure of Directors or Certain Officers
16 Sep 22
8-K
LogicBio Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
15 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
21 Jun 22
Registration and prospectus
15-12G
Securities registration termination
29 Nov 22
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Nov 22
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Nov 22
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Nov 22
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Nov 22
POS AM
Prospectus update (post-effective amendment)
16 Nov 22
25-NSE
Exchange delisting
16 Nov 22
SC 14D9/A
Tender offer solicitation (amended)
16 Nov 22
SC TO-T/A
Third party tender offer statement (amended)
16 Nov 22
SC 14D9
Tender offer solicitation
18 Oct 22
Proxies
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
27 Apr 21
DEF 14A
Definitive proxy
27 Apr 21
DEFA14A
Additional proxy soliciting materials
5 Jun 20
DEFA14A
Additional proxy soliciting materials
29 Apr 20
DEF 14A
Definitive proxy
29 Apr 20
DEFA14A
Additional proxy soliciting materials
29 Apr 19
DEF 14A
Definitive proxy
29 Apr 19
Other
EFFECT
Notice of effectiveness
21 Nov 22
CT ORDER
Confidential treatment order
23 Mar 22
CT ORDER
Confidential treatment order
16 Jul 21
SEC STAFF
SEC staff action: Order
19 Apr 21
SEC STAFF
SEC staff action: Order
22 Mar 21
UPLOAD
Letter from SEC
8 Jun 20
CORRESP
Correspondence with SEC
5 Jun 20
UPLOAD
Letter from SEC
28 May 20
EFFECT
Notice of effectiveness
26 Nov 19
CORRESP
Correspondence with SEC
21 Nov 19
Ownership
SC 13G/A
Beryl Capital Management LLC
14 Feb 23
SC 13D/A
Arix Bioscience plc
10 Feb 23
4
Mark A Kay
17 Nov 22
4
Mark J Enyedy
17 Nov 22
4
Mariana Nacht
17 Nov 22
4
MICHAEL S WYZGA
17 Nov 22
4
Frederic Chereau
17 Nov 22
4
RICHARD A MOSCICKI
17 Nov 22
4
Jeff Goater
17 Nov 22
4
Daphne Karydas
17 Nov 22